Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer

Author： Marino P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.11, 2003-01, pp. : 807-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M.   Stein S.   Stadtmauer E.A.  

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite

Lower costs with sequential high-dose chemotherapy in breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy in Breast Cancer

By Lake Diana E.   Hudis Clifford A.  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1851-1860

Adis International

Access to resources Recommend Favorite

Pharmacogenetics: useful tool for tailoring chemotherapy?

By  

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

High-dose chemotherapy effective in advanced sarcoma?

By  

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite